| Stereoselective plasma protein binding of amlodipine S Maddi, MR Yamsani, A Seeling, GKE Scriba Chirality: The Pharmacological, Biological, and Chemical Consequences of …, 2010 | 36 | 2010 |
| Effect of silymarin on the oral bioavailability of ranitidine in healthy human volunteers BN Rao, M Srinivas, YS Kumar, YM Rao Drug metabolism and drug interactions 22 (2-3), 175-186, 2007 | 31 | 2007 |
| Discovery of novel pyrido-pyrrolidine hybrid compounds as alpha-glucosidase inhibitors and alternative agent for control of type 1 diabetes T Luthra, V Banothu, U Adepally, K Kumar, M Swathi, S Chakrabarti, ... European journal of medicinal chemistry 188, 112034, 2020 | 25 | 2020 |
| Development and validation of a stereoselective HPLC method for the determination of the in vitro transport of nateglinide enantiomers in rat intestine S Maddi, S Keshetty, C Mohan Ega, M Rao Yamasani, GKE Scriba Journal of separation science 30 (12), 1875-1880, 2007 | 21 | 2007 |
| Cytochrome P450 enzymes, drug transporters and their role in pharmacokinetic drug-drug interactions of xenobiotics: a comprehensive review S Maddi, T Goud, P Srivastava, E Ilhan, T Ugurlu, O Kerimoglu Open Journal of Chemistry 3 (1), 001-011, 2017 | 20 | 2017 |
| New chiral reverse phase hplc method for determination of atenolol enantiomers in pharmaceutical formulations CM Eaga, JM Somagoni, SR Maddi, S Reddy, MR Yamsani International Journal of Pharmaceutical Sciences Review & Research 4 (1), 2010 | 11 | 2010 |
| Optimization of nicotinamides as potent and selective IRAK4 inhibitors with efficacy in a murine model of psoriasis S Nair, SR Kumar, VR Paidi, R Sistla, D Kantheti, SR Polimera, ... ACS Medicinal Chemistry Letters 11 (7), 1402-1409, 2020 | 9 | 2020 |
| Degradation study of irbesartan: Isolation and structural elucidation of novel degradants VAK Mutha, S Guduru, M Kaliyaperumal, CS Rumalla, SR Maddi, ... Journal of Pharmaceutical and Biomedical Analysis 157, 180-188, 2018 | 9 | 2018 |
| Role of in vitro two-dimensional (2D) and three-dimensional (3D) cell culture systems for ADME-Tox screening in drug discovery and development: a comprehensive review SM Venkatesh Chunduri ADMET&DMPK, 1-32, 2022 | 7* | 2022 |
| Altered pharmacokinetics and pharmacodynamics of repaglinide by ritonavir in rats with healthy, diabetic and impaired hepatic function T Goud, S Maddi, D Nayakanti, RP Thatipamula Drug Metabolism and Personalized Therapy 31 (2), 123-130, 2016 | 7 | 2016 |
| Stereoselective binding of chiral anti-diabetic drug nateglinide to plasma proteins S Maddi, G Scriba, MR Yamsani Walter de Gruyter 26 (2), 81-86, 2011 | 6 | 2011 |
| Evaluation of pharmacokinetic and pharmacodynamic interaction between repaglinide and atazanavir in healthy, diabetic and hepatic impaired rats: possible inhibition of CYP3A … T Goud, S Maddi, N Devanna, TR Prasad ADMET and DMPK 4 (3), 269-279, 2016 | 5 | 2016 |
| Evidence of stereoselective and segmental-dependant transport of chiral antidiabetic drug nateglinide along the rat small intestine: possible role of efflux transporters S Maddi, SK Yamsani, A Devandla, G Scriba, MR Yamsani Medicinal Chemistry Research 22, 2403-2410, 2013 | 3 | 2013 |
| Developing C2-Aroyl Indoles as Novel Inhibitors of IDO1 and Understanding Their Mechanism of Inhibition via Mass Spectroscopy, QM/MM Calculations and … J Chauhan, SR Maddi, KD Dubey, S Sen Frontiers in Chemistry 9, 691319, 2021 | 2 | 2021 |
| Discovery of pyridine amide based inhibitors of interleukin receptor-associated kinase 4 (IRAK4) for the treatment of lupus J Hynes, S Nair, W Pitts, R Bhide, R Schmidt, S Spergel, VRR Paidi, ... ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 252, 2016 | 2 | 2016 |
| Discovery and characterization of a selective TrkA inhibitor for the treatment of TrkA-driven cancers VG Tirunagaru, K Nagaswamy, S Mitra, S Maddi, RS Adluri, H Joshi, ... Cancer Research 76 (14_Supplement), 2643-2643, 2016 | 2 | 2016 |
| Discovery of selective PI3Kβ inhibitors for PTEN deficient tumors and other indications AR Chowdhury, JD Athisayamani, S Mitra, S Maddi, RS Adluri, SR Bethi, ... Cancer Res 14, 373, 2016 | 2 | 2016 |
| A Validated HPLC Method for the Simultaneous Quantification of Curcumin, Silybin, and Psoralen: Application to Phytopharmaceuticals B Shaik, A Eerla, S Palatheeya, PR Veerareddy, S Maddi Revista Brasileira de Farmacognosia 33 (3), 610-616, 2023 | 1 | 2023 |
| Pharmacokinetics of PLK2 inhibitor GBO-006-1, developed as a novel first-in-class molecule to treat triple negative breast cancer A Roychowdhury, AJ Duraiswamy, S Maddi, C Deb, S Mitra, R Reddy, ... Cancer Research 74 (19_Supplement), 4537-4537, 2014 | 1 | 2014 |
| Molecular Interaction Analysis of Phytochemicals as the Prospective Potential Multi-Target Inhibitors Related to Psoriasis and Other Autoimmune Disorders B Swain, S Maddi Journal of Drug Design and Medicinal Chemistry 10 (1), 16-30, 2024 | | 2024 |
E.Premkumar ReddyProfessor & Director, Mount Sinai School of Medicine, New York, NY在 mssm.edu 的电子邮件经过验证
E.Premkumar ReddyProfessor & Director, Mount Sinai School of Medicine, New York, NY在 mssm.edu 的电子邮件经过验证
Jatiani S SMount Sinai Medical Center在 mssm.edu 的电子邮件经过验证